Are you Dr. Wolf?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 39 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1977 Butler Blvd
Ste E6200
Houston, TX 77030Phone+1 713-798-6131Fax+1 713-798-3252
Summary
- Dr. John Wolf, MD is a board certified dermatologist in Houston, Texas. He is currently licensed to practice medicine in Texas and California. He is affiliated with Michael E. DeBakey Department of Veterans Affairs Medical Center, St. Luke's Health - Baylor St. Luke's Medical Center, and Texas Children's Hospital.
Education & Training
University of California (San Francisco)Residency, Dermatology, 1969 - 1972
NYU Grossman School of MedicineInternship, Internal Medicine, 1965 - 1966
University of Texas Medical Branch School of MedicineClass of 1965
Certifications & Licensure
CA State Medical License 1969 - Present
TX State Medical License 1965 - 2025- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- Perforating lichen nitidus in the setting of atopic dermatitis.David Gustafson, John E Wolf, Laura Lester, Hans Sander
Journal of Cutaneous Pathology. 2024-02-01 - Vaccines Hesitancy and the Dermatologist.Peter J. Hotez, John E. Wolf
Skinmed. 2018-01-01 - 5 citationsCutaneous metastasis to the scalp as the primary presentation of colorectal adenocarcinoma.Sarita R. Shah, Danielle S. Applebaum, Silvia Potenziani, Yve Huttenbach, John E. Wolf
Dermatology Online Journal. 2017-11-15
Press Mentions
How to Address Rosacea Patients’ Toughest in-Office QuestionsApril 28th, 2023
The Unspoken Potential of Rosacea TreatmentsSeptember 24th, 2019
Rosacea Prevalence Revised Upward: 415 Million Potential Cases WorldwideJuly 11th, 2018- Join now to see all
